MENU
PTGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Protagonist Therapeutics (PTGX) Ownership - Who owns Protagonist Therapeutics?
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
112
Web
https://www.protagonist-inc.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.72B
P/E Ratio
10.49
Total Cash
418.91M
Projected Growth
N/A
Total Debt
10.87M
Revenue
434.43M
Risk (Beta)
1.54
Dividend Yield
N/A
Total Cash/Share
6.82
Total Debt/Equity
N/A
Revenue/Share
6.68 USD as % of share price
Fundamentals
PTGX
Capitalization
2.73B
P/E Ratio
10.49
Risk (Beta)
1.54
Dividend Yield
N/A
Total Cash
419M
Total Cash/Share
6.82
Total Debt
10.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.68%
Revenue
434M
ROE
N/A
Book Value
675M
P/B Ratio
4.04
Cash Flow
N/A
Earnings
4.47
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
12.48
Current Revenue Per Employee
1354269.90
Dividends Per Share - Security
N/A
EBITDA
256M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
49.91
Shares Held By Institutions
3.7B
Shares Outstanding - Current
61.4M
Total Liabilities
69.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
15.000
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of disulfide-rich peptides
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
112
Web
https://www.protagonist-inc.com